The Valley Desk

NCT05263999 · Interventional trial

A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)

Overall registry status Terminated

Phase 3

Conditions Acute GVHD, Acute-graft-versus-host Disease, GVHD, Graft Versus Host Disease, aGVHD

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov